Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lachmann

Showing results (301-310 of 426) with videos related to

Pageof 43
Sort By:
Human Gene Therapy|March 16, 2022
Conversion of the Liver into a Biofactory for DNaseI Using Adeno-Associated Virus Vector Gene Transfer Reduces Neutrophil Extracellular Traps in a Model of Systemic Lupus ErythematosusAmina Ahmad, Mawj Mandwie, Kim M O'Sullivan, et al.
Arthritis Research & Therapy|December 14, 2011
Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal studyIsabelle Koné-Paut, Helen J Lachmann, Jasmin B Kuemmerle-Deschner, et al.
Arthritis and Rheumatism|January 3, 2013
AA amyloidosis complicating the hereditary periodic fever syndromesThirusha Lane, Jutta M Loeffler, Dorota M Rowczenio, et al.
Haematologica|August 11, 2019
Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteriaFaye A Sharpley, Marianna Fontana, Ana Martinez-Naharro, et al.
Blood|October 1, 1985
Characterization of patients with an increased susceptibility to bacterial infections and a genetic deficiency of leukocyte membrane complement receptor type 3 and the related membrane antigen LFA-1G D Ross, R A Thompson, M J Walport, et al.
American Journal of Clinical Pathology|June 30, 2016
Comparison of Free Light Chain Assays:  Freelite and N Latex in Diagnosis, Monitoring, and Predicting Survival in Light Chain AmyloidosisShameem Mahmood, Nancy L Wassef, Simon J Salter, et al.
Pediatric Rheumatology Online Journal|March 23, 2018
The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international surveyJerold Jeyaratnam, Nienke M Ter Haar, Helen J Lachmann, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 4, 2019
Exploratory Study of MYD88 L265P, Rare NLRP3 Variants, and Clonal Hematopoiesis Prevalence in Patients With Schnitzler SyndromeShelly Pathak, Dorota M Rowczenio, Roger G Owen, et al.
Allergy|January 22, 2013
Unexplained recurrent fever: when is autoinflammation the explanation?T Kallinich, M Gattorno, C E Grattan, et al.
Blood|October 4, 2019
A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomibRicha Manwani, Oliver Cohen, Faye Sharpley, et al.
Pageof 43

Showing results (301-310 of 426) with videos related to

Sort By:
Pageof 43
Human Gene Therapy|March 16, 2022
Conversion of the Liver into a Biofactory for DNaseI Using Adeno-Associated Virus Vector Gene Transfer Reduces Neutrophil Extracellular Traps in a Model of Systemic Lupus ErythematosusAmina Ahmad, Mawj Mandwie, Kim M O'Sullivan, et al.
Arthritis Research & Therapy|December 14, 2011
Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal studyIsabelle Koné-Paut, Helen J Lachmann, Jasmin B Kuemmerle-Deschner, et al.
Arthritis and Rheumatism|January 3, 2013
AA amyloidosis complicating the hereditary periodic fever syndromesThirusha Lane, Jutta M Loeffler, Dorota M Rowczenio, et al.
Haematologica|August 11, 2019
Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteriaFaye A Sharpley, Marianna Fontana, Ana Martinez-Naharro, et al.
Blood|October 1, 1985
Characterization of patients with an increased susceptibility to bacterial infections and a genetic deficiency of leukocyte membrane complement receptor type 3 and the related membrane antigen LFA-1G D Ross, R A Thompson, M J Walport, et al.
American Journal of Clinical Pathology|June 30, 2016
Comparison of Free Light Chain Assays:  Freelite and N Latex in Diagnosis, Monitoring, and Predicting Survival in Light Chain AmyloidosisShameem Mahmood, Nancy L Wassef, Simon J Salter, et al.
Pediatric Rheumatology Online Journal|March 23, 2018
The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international surveyJerold Jeyaratnam, Nienke M Ter Haar, Helen J Lachmann, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 4, 2019
Exploratory Study of MYD88 L265P, Rare NLRP3 Variants, and Clonal Hematopoiesis Prevalence in Patients With Schnitzler SyndromeShelly Pathak, Dorota M Rowczenio, Roger G Owen, et al.
Allergy|January 22, 2013
Unexplained recurrent fever: when is autoinflammation the explanation?T Kallinich, M Gattorno, C E Grattan, et al.
Blood|October 4, 2019
A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomibRicha Manwani, Oliver Cohen, Faye Sharpley, et al.
Pageof 43